by Cort Johnson | Sep 19, 2026 | Endoplasmic Reticulum , Energy Production , Homepage , Inflammation , IVO-21 , Oxidative Stress , Treatment
Could a new mitochondrial drug called IVO-21 be the answer to the energy problems in ME/CFS, fibromyalgia, and long COVID?
by Cort Johnson | Sep 12, 2026 | B-cells , Brain , Cingulate cortex , Endoplasmic Reticulum , Energy Production , Extracellular matrix , Homepage , Locus coeruleus , Metabolism , Muscles , Neuroinflammation , Oxidative Stress , T-cells
A mitochondrial disrupter called WASF3 could be dysregulating many systems in ME/CFS.
by Cort Johnson | Jun 2, 2024 | Autonomic Nervous System , B-cells , Brain , Brainstem , Cerebral Spinal Fluid , Conference Reports , Dopamine , Endoplasmic Reticulum , Energy Production , Gut , Homepage , Immune , Inflammation , Klimas , Lipids , Metabolism , Microbiome , Motor Cortex , Muscles , T-cells
The findings from a seminal (and massive) NIH intramural study done on chronic fatigue syndrome (ME/CFS) were explained during a symposium.
by Cort Johnson | Oct 21, 2023 | Artificial Intelligence , Endoplasmic Reticulum , Homepage , Liver , Liver and urea cycle
An artificial intelligence driven hunt for the cause of chronic fatigue syndrome (ME/CFS) picked up clues that studies only later suggested might be core problems
by Cort Johnson | Aug 16, 2023 | Endoplasmic Reticulum , Energy Production , Homepage , ME/CFS , Metabolism , Muscles , Oxidative Stress , Pathogens , Research
NIH researchers dig deep to find a new mitochondrial abnormality called WASF3 in chronic fatigue syndrome (ME/CFS). A clinical trial is expected.